Senti Biosciences (SNTI) Revenue (2021 - 2023)

Senti Biosciences' quarterly Revenue came in at $338000.0 in Q3 2023, down 77.7% year-on-year from $1.5 million in Q3 2022, and down 50.8% quarter-over-quarter from $687000.0 in Q2 2023.

Senti Biosciences has reported Revenue for 3 years, with the latest figure at $338000.0 in Q3 2023.

  • For the quarter ending Q3 2023, Revenue fell 77.7% year-over-year to $338000.0; the trailing twelve-month figure through Jun 2024 stood at $338000.0 (down 89.75% YoY), and the FY2025 full-year result was $22000.0, changed N/A from the prior year.
  • Revenue for Q3 2023 stood at $338000.0, down from $687000.0 in the prior quarter.
  • The five-year high for Revenue was $1.5 million in Q3 2022, with the low at -$191000.0 in Q4 2022.
  • Average Revenue over 3 years is $852200.0, with a median of $948000.0 recorded in 2021.
  • Peak annual rise in Revenue reached 42.42% in 2022, while the deepest fall reached 124.09% in 2022.
  • Tracing SNTI's Revenue over 3 years: stood at $793000.0 in 2021, then tumbled by 124.09% to -$191000.0 in 2022, then surged by 276.96% to $338000.0 in 2023.
  • The last three Revenue figures came in at $338000.0 (Q3 2023), $687000.0 (Q2 2023), and $1.3 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Senti Biosciences Holdings 22.25 Mn 22.25 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 338,000.00
Jun 30, 2023 687,000.00
Mar 31, 2023 1.29 Mn
Dec 31, 2022 -191,000.00
Sep 30, 2022 1.52 Mn
Jun 30, 2022 1.11 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 793,000.00
Sep 30, 2021 1.10 Mn
Jun 30, 2021 778,000.00